These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 21487652)

  • 1. Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized/castrated mice via both 5-HT reuptake inhibition and σ(1) receptor activation.
    Ago Y; Yano K; Hiramatsu N; Takuma K; Matsuda T
    Psychopharmacology (Berl); 2011 Oct; 217(3):377-86. PubMed ID: 21487652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of 5-HT1A and σ1 receptor activation on prefrontal dopaminergic transmission under circulating steroid deficiency.
    Hiramatsu N; Ago Y; Hasebe S; Nishimura A; Mori K; Takuma K; Matsuda T
    Neuropharmacology; 2013 Dec; 75():53-61. PubMed ID: 23851260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of GABAA receptors in 5-HT1A and σ1 receptor synergism on prefrontal dopaminergic transmission under circulating neurosteroid deficiency.
    Ago Y; Hasebe S; Hiramatsu N; Mori K; Watabe Y; Onaka Y; Hashimoto H; Takuma K; Matsuda T
    Psychopharmacology (Berl); 2016 Sep; 233(17):3125-34. PubMed ID: 27339616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice.
    de Groote L; Olivier B; Westenberg HG
    Psychopharmacology (Berl); 2002 Aug; 162(4):419-24. PubMed ID: 12172696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex.
    Ago Y; Nakamura S; Baba A; Matsuda T
    Neuropsychopharmacology; 2005 Jan; 30(1):43-51. PubMed ID: 15383832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine.
    Egashira N; Harada S; Okuno R; Matsushita M; Nishimura R; Mishima K; Iwasaki K; Orito K; Fujiwara M
    Eur J Pharmacol; 2007 Jun; 563(1-3):149-54. PubMed ID: 17349995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [JSNP Excellent Presentation Award for AsCNP 2011: involvement of 5-HT(1A) receptors in fluvoxamine-induced enhancement of prefrontal dopamine release].
    Hiramatsu N; Ago Y; Yano K; Takuma K; Matsuda M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Apr; 32(2):117-8. PubMed ID: 22708271
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of the 5-HT1A autoreceptor in the enhancement of fluvoxamine-induced increases in prefrontal dopamine release by adrenalectomy/castration in mice.
    Hasebe S; Hiramatsu N; Ago Y; Mori K; Watabe Y; Hashimoto H; Takuma K; Matsuda T
    J Pharmacol Sci; 2015 Feb; 127(2):232-5. PubMed ID: 25727963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-anhedonic effect of selective serotonin reuptake inhibitors with affinity for sigma-1 receptors in picrotoxin-treated mice.
    Hasebe S; Ago Y; Watabe Y; Oka S; Hiramatsu N; Tanaka T; Umehara C; Hashimoto H; Takuma K; Matsuda T
    Br J Pharmacol; 2017 Feb; 174(4):314-327. PubMed ID: 27987210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.
    Bymaster FP; Zhang W; Carter PA; Shaw J; Chernet E; Phebus L; Wong DT; Perry KW
    Psychopharmacology (Berl); 2002 Apr; 160(4):353-61. PubMed ID: 11919662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacology of combined activation of the serotonin
    Ago Y; Hasebe S; Hiramatsu N; Hashimoto H; Takuma K; Matsuda T
    Eur J Pharmacol; 2017 Aug; 809():172-177. PubMed ID: 28529139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
    De Groote L; Olivier B; Westenberg HG
    Eur J Pharmacol; 2002 Mar; 439(1-3):93-100. PubMed ID: 11937097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats.
    Kitaichi Y; Inoue T; Nakagawa S; Boku S; Kakuta A; Izumi T; Koyama T
    Eur J Pharmacol; 2010 Nov; 647(1-3):90-6. PubMed ID: 20816814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological interaction with the sigma1 (σ1)-receptor in the acute behavioral effects of antidepressants.
    Villard V; Meunier J; Chevallier N; Maurice T
    J Pharmacol Sci; 2011; 115(3):279-92. PubMed ID: 21427517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways.
    Nishimura T; Ishima T; Iyo M; Hashimoto K
    PLoS One; 2008 Jul; 3(7):e2558. PubMed ID: 18596927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors.
    McMahon LR; Cunningham KA
    Neuropsychopharmacology; 2001 Mar; 24(3):319-29. PubMed ID: 11166521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P; Kehr J; Scheel-Krüger J
    J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
    Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; De Montigny C; Blier P
    Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice.
    Miura H; Qiao H; Kitagami T; Ohta T; Ozaki N
    Psychopharmacology (Berl); 2005 Jan; 177(3):307-14. PubMed ID: 15290002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.